Theralase® Releases FY2022 Audited Financial Statements
April 26, 2023 18:01 ET
|
Theralase Technologies Inc.
TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
Theralase® Phase Ib NMIBC Clinical Study Published
June 21, 2022 07:00 ET
|
Theralase Technologies Inc.
TORONTO, June 21, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
CAST Founder to Speak at BCG-led Virtual Software Intelligence Forum 2022
January 10, 2022 10:07 ET
|
CAST Software Inc.
NEW YORK and PARIS, Jan. 10, 2022 (GLOBE NEWSWIRE) -- CAST Founder & CEO, Vincent Delaroche, will be joining Benjamin Rehberg, BCG Senior Partner & Head of Technology Practice NA, as he...
Theralase Releases 3Q21 Financial Statements and Newsletter
November 29, 2021 18:00 ET
|
Theralase Technologies Inc.
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
SESN NOTICE: Rosen, Trusted Investor Counsel, Encourages Sesen Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 18 Deadline in Securities Class Action – SESN
October 13, 2021 18:15 ET
|
The Rosen Law Firm PA
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Sesen Bio, Inc. (NASDAQ: SESN) between December 21, 2020...
Theralase Releases Q221 Unaudited Financial Statements and Quarterly Newsletter
August 30, 2021 18:15 ET
|
Theralase Technologies Inc.
TORONTO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), A clinical stage pharmaceutical company dedicated to the research...
Theralase® Launches Seventh US-Based Clinical Study Site and Treats First Patient in the US
June 11, 2021 07:00 ET
|
Theralase Technologies Inc.
TORONTO, June 11, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
Boston Consulting Group Is Named Top Leader of Organization Strategy Consulting Worldwide
December 17, 2018 10:01 ET
|
BCG
BOSTON, Dec. 17, 2018 (GLOBE NEWSWIRE) -- ALM Intelligence has named Boston Consulting Group (BCG) the top leader in organization strategy worldwide for the second year in a row. The latest edition...
In Times of Volatility and Uncertainty, Companies Should Refocus on the Real Essence of Value Creation
November 27, 2018 00:01 ET
|
BCG
BOSTON, Nov. 27, 2018 (GLOBE NEWSWIRE) -- During the ten-year bull market, companies’ share prices seemed almost to soar at will: ten years of uninterrupted economic growth and low interest rates...
It’s Time to Future-Proof Your Workers’ Skills
November 14, 2018 09:54 ET
|
BCG
Both Workers and Employers Acknowledge the Need for New Skills but No System Is in Place to Provide Those Skills. Building a System Requires a Mindset Shift, According to a New Study from the Adecco...